Works matching IS 18607179 AND DT 2020 AND VI 15 AND IP 1

Results: 20

Cover Feature: Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships (ChemMedChem 1/2020).

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 2, doi. 10.1002/cmdc.201900691

By:

Asquith, Christopher R. M.;
Laitinen, Tuomo;
Bennett, James M.;
Wells, Carrow I.;
Elkins, Jonathan M.;
Zuercher, William J.;
Tizzard, Graham J.;
Poso, Antti

Publication type:

Article

Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020).

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 1, doi. 10.1002/cmdc.201900683

By:

Pillow, Thomas H.;
Adhikari, Pragya;
Blake, Robert A.;
Chen, Jinhua;
Del Rosario, Geoffrey;
Deshmukh, Gauri;
Figueroa, Isabel;
Gascoigne, Karen E.;
Kamath, Amrita V.;
Kaufman, Susan;
Kleinheinz, Tracy;
Kozak, Katherine R.;
Latifi, Brandon;
Leipold, Douglas D.;
Sing Li, Chun;
Li, Ruina;
Mulvihill, Melinda M.;
O'Donohue, Aimee;
Rowntree, Rebecca K.;
Sadowsky, Jack D.

Publication type:

Article

Volume 15—Change is Coming!

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 3, doi. 10.1002/cmdc.201900660

By:

Peralta, David

Publication type:

Article

New Challenges in Drug Discovery – July 8–11, 2019, Vitoria‐Gasteiz, Spain.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 168, doi. 10.1002/cmdc.201900627

By:

Alonso, Concepción;
Santos, Jesús M.;
Palacios, Francisco

Publication type:

Article

Epigenetic Drug Discovery. Edited by Wolfgang Sippl and Manfred Jung.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 174, doi. 10.1002/cmdc.201900615

By:

Vazquez‐Rodriguez, Saleta

Publication type:

Article

The 12th AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 162, doi. 10.1002/cmdc.201900623

By:

Olgac, Abdurrahman;
Yalcin, Ismail;
Aki‐Yalcin, Esin

Publication type:

Article

Successful Drug Discovery, Volume 4. Edited by János Fischer, Christian Klein, and Wayne E. Childers.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 173, doi. 10.1002/cmdc.201900599

By:

Langer, Thierry;
Bryant, Sharon D.

Publication type:

Article

Toxicology and Risk Assessment: A Comprehensive Introduction, 2nd Edition. Edited by Helmut Greim and Robert Snyder.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 172, doi. 10.1002/cmdc.201900586

By:

Dietrich, Cornelia;
Weiss, Carsten

Publication type:

Article

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 50, doi. 10.1002/cmdc.201900576

By:

Schierle, Simone;
Helmstädter, Moritz;
Schmidt, Jurema;
Hartmann, Markus;
Horz, Maximiliane;
Kaiser, Astrid;
Weizel, Lilia;
Heitel, Pascal;
Proschak, Anna;
Hernandez‐Olmos, Victor;
Proschak, Ewgenij;
Merk, Daniel

Publication type:

Article

Discovery of Biased Mu‐Opioid Receptor Agonists for the Treatment of Pain.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 155, doi. 10.1002/cmdc.201900575

By:

Ma, Mengjun;
Li, Xiang;
Tong, Kun;
Cheng, Jingchao;
Yu, Zixing;
Ren, Fengxia;
Zhong, Bohua;
Shi, Weiguo

Publication type:

Article

Poly[N‐(2‐hydroxypropyl)methacrylamide]‐Modified Magnetic γ‐F2O3 Nanoparticles Conjugated with Doxorubicin for Glioblastoma Treatment.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 96, doi. 10.1002/cmdc.201900564

By:

Plichta, Zdeněk;
Horák, Daniel;
Mareková, Dana;
Turnovcová, Karolína;
Kaiser, Radek;
Jendelová, Pavla

Publication type:

Article

Sidechain Diversification of Grandifloracin Allows Identification of Analogues with Enhanced Anti‐Austerity Activity against Human PANC‐1 Pancreatic Cancer Cells.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 125, doi. 10.1002/cmdc.201900549

By:

Alexander, Benjamin E.;
Sun, Sijia;
Palframan, Matthew J.;
Kociok‐Köhn, Gabriele;
Dibwe, Dya Fita;
Watanabe, Shiro;
Caggiano, Lorenzo;
Awale, Suresh;
Lewis, Simon E.

Publication type:

Article

Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget‐Directed Hydrazone Ruthenium(II)–Arene Complexes.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 105, doi. 10.1002/cmdc.201900551

By:

Cuccioloni, Massimiliano;
Bonfili, Laura;
Cecarini, Valentina;
Nabissi, Massimo;
Pettinari, Riccardo;
Marchetti, Fabio;
Petrelli, Riccardo;
Cappellacci, Loredana;
Angeletti, Mauro;
Eleuteri, Anna Maria

Publication type:

Article

Monocyclic Quinone Structure‐Activity Patterns: Synthesis of Catalytic Inhibitors of Topoisomerase II with Potent Antiproliferative Activity.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 114, doi. 10.1002/cmdc.201900548

By:

Waugh, Thomas M.;
Masters, John;
Aliev, Abil E.;
Marson, Charles M.

Publication type:

Article

Potential Therapeutic Effects of Mg/HCOOH Metal Organic Framework on Relieving Osteoarthritis.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 13, doi. 10.1002/cmdc.201900546

By:

Li, Zhen;
Peng, Ying;
Pang, Xiangchao;
Tang, Bin

Publication type:

Article

Structure−Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 68, doi. 10.1002/cmdc.201900544

By:

Bernal, Freddy A.;
Kaiser, Marcel;
Wünsch, Bernhard;
Schmidt, Thomas J.

Publication type:

Article

Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 136, doi. 10.1002/cmdc.201900542

By:

De Pascale, Martina;
Iacopetta, Domenico;
Since, Marc;
Corvaisier, Sophie;
Vie, Véronique;
Paboeuf, Gilles;
Hennequin, Didier;
Perato, Serge;
De Giorgi, Marcella;
Sinicropi, Maria Stefania;
Sopkova‐De Oliveira Santos, Jana;
Voisin‐Chiret, Anne‐Sophie;
Malzert‐Freon, Aurélie

Publication type:

Article

Synthesis and Structure‐Activity Relationships of N‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 79, doi. 10.1002/cmdc.201900536

By:

De Vita, Elena;
Smits, Niels;
Hurk, Helma;
Beck, Elizabeth M.;
Hewitt, Joanne;
Baillie, Gemma;
Russell, Emily;
Pannifer, Andrew;
Hamon, Véronique;
Morrison, Angus;
McElroy, Stuart P.;
Jones, Philip;
Ignatenko, Natalia A.;
Gunkel, Nikolas;
Miller, Aubry K.

Publication type:

Article

Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 26, doi. 10.1002/cmdc.201900521

By:

Asquith, Christopher R. M.;
Laitinen, Tuomo;
Bennett, James M.;
Wells, Carrow I.;
Elkins, Jonathan M.;
Zuercher, William J.;
Tizzard, Graham J.;
Poso, Antti

Publication type:

Article

Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity.

Published in:

ChemMedChem, 2020, v. 15, n. 1, p. 17, doi. 10.1002/cmdc.201900497

By:

Pillow, Thomas H.;
Adhikari, Pragya;
Blake, Robert A.;
Chen, Jinhua;
Del Rosario, Geoffrey;
Deshmukh, Gauri;
Figueroa, Isabel;
Gascoigne, Karen E.;
Kamath, Amrita V.;
Kaufman, Susan;
Kleinheinz, Tracy;
Kozak, Katherine R.;
Latifi, Brandon;
Leipold, Douglas D.;
Sing Li, Chun;
Li, Ruina;
Mulvihill, Melinda M.;
O'Donohue, Aimee;
Rowntree, Rebecca K.;
Sadowsky, Jack D.

Publication type:

Article

Works matching IS 18607179 AND DT 2020 AND VI 15 AND IP 1

Cover Feature: Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships (ChemMedChem 1/2020).

Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020).

Volume 15—Change is Coming!

New Challenges in Drug Discovery – July 8–11, 2019, Vitoria‐Gasteiz, Spain.

Epigenetic Drug Discovery. Edited by Wolfgang Sippl and Manfred Jung.

The 12<sup>th</sup> AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.

Successful Drug Discovery, Volume 4. Edited by János Fischer, Christian Klein, and Wayne E. Childers.

Toxicology and Risk Assessment: A Comprehensive Introduction, 2nd Edition. Edited by Helmut Greim and Robert Snyder.

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.

Discovery of Biased Mu‐Opioid Receptor Agonists for the Treatment of Pain.

Poly[N‐(2‐hydroxypropyl)methacrylamide]‐Modified Magnetic γ‐F<sub>2</sub>O<sub>3</sub> Nanoparticles Conjugated with Doxorubicin for Glioblastoma Treatment.

Sidechain Diversification of Grandifloracin Allows Identification of Analogues with Enhanced Anti‐Austerity Activity against Human PANC‐1 Pancreatic Cancer Cells.

Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget‐Directed Hydrazone Ruthenium(II)–Arene Complexes.

Monocyclic Quinone Structure‐Activity Patterns: Synthesis of Catalytic Inhibitors of Topoisomerase II with Potent Antiproliferative Activity.

Potential Therapeutic Effects of Mg/HCOOH Metal Organic Framework on Relieving Osteoarthritis.

Structure−Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.

Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes.

Synthesis and Structure‐Activity Relationships of N‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6.

Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships.

Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity.